secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193805-24-000806
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus stockholders approve 2M share increase to equity incentive plan at annual meeting
--------------------------------------------------------------------------------

- Amendment to 2019 Omnibus Equity Incentive Plan approved: shares increased by 2,000,000 to 10,750,000 total.
- All eight director nominees elected (e.g., Peter Farrell, Joseph Payne) to serve until 2025 annual meeting.
- Say-on-pay approved with 19,875,930 For, 1,069,592 Against, 58,600 Abstain.
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 ratified (23,267,449 For).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/0001193805-24-000806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/e663711_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-000806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer